Back to funds

DAFNA Capital Management LLC

Updated 6 days ago

Managed by Dafna Capital Management Llc • Latest filing Q3 2026

Portfolio value
$468.1M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$430.5M
Q1 2026$439.6M
Q2 2026$524.4M
Q3 2026$468.1M

Top holdings

87 positions as of Q3 2026

View filing
R

REVOLUTION MEDICINES INC

Value
$100M
Shares
487.1K
% Port
21.36%
A

ATRICURE INC

Value
$29.4M
Shares
522.7K
% Port
6.28%
C

COMPASS PATHWAYS PLC

Value
$26.6M
Shares
2.14M
% Port
5.68%
S

SPDR S&P BIOTECH ETF

Value
$23.9M
Shares
151.5K
% Port
5.10%
N

NEKTAR THERAPEUTICS

Value
$19.6M
Shares
323.4K
% Port
4.18%
I

IDEAYA BIOSCIENCES INC

Value
$16.9M
Shares
438.7K
% Port
3.60%
S

STEREOTAXIS INC

Value
$16.8M
Shares
13.68M
% Port
3.60%
D

DENALI THERAPEUTICS INC

Value
$15.4M
Shares
744.0K
% Port
3.29%
A

ASCENDIS PHARMA A/S

Value
$11.4M
Shares
50.0K
% Port
2.43%
R

ARCUS BIOSCIENCES INC

Value
$11.4M
Shares
439.8K
% Port
2.43%
C

CYTOKINETICS INC

Value
$11.3M
Shares
172.0K
% Port
2.42%
E

EDGEWISE THERAPEUTICS INC

Value
$9M
Shares
221.8K
% Port
1.92%
N

NEUROCRINE BIOSCIENCES INC

Value
$8.9M
Shares
62.7K
% Port
1.90%
P

INSULET CORP

Value
$8.9M
Shares
67.9K
% Port
1.89%
X

XENON PHARMACEUTICALS INC

Value
$7.6M
Shares
204.8K
% Port
1.63%
A

AXOGEN INC

Value
$7.5M
Shares
180.0K
% Port
1.61%
D

DEXCOM INC

Value
$7.4M
Shares
86.3K
% Port
1.59%
S

SYNDAX PHARMACEUTICALS INC

Value
$6.2M
Shares
331.3K
% Port
1.33%
L

LARIMAR THERAPEUTICS INC

Value
$6M
Shares
1.89M
% Port
1.29%
T

TANDEM DIABETES CARE INC

Value
$5.8M
Shares
355.2K
% Port
1.24%

Explore